Pegylated Liposomal Doxorubicin or Epirubicin in Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer.
Clinical trial NCT03983096 · COMPLETED
Trial details
- NCT number
- NCT03983096
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-07-07
- Primary completion
- 2020-05-01
- Enrollment
- 1213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.